Enzyme-Responsive Materials as Carriers for Improving Photodynamic Therapy

Area of Science:

• Biomaterials Science
• Oncology
• Photochemistry

Background:

• Photodynamic therapy (PDT) utilizes photosensitizers (PS) and light to generate reactive oxygen species (ROS) for cancer treatment.
• Limited tumor targeting of PS hinders PDT's clinical efficacy and increases side effects.
• Tumor microenvironments possess unique enzymatic characteristics exploitable for targeted drug delivery.

Purpose of the Study:

• To review the application of enzyme-responsive materials (ERMs) in photodynamic therapy (PDT).
• To discuss the potential of ERMs as carriers for photosensitizers (PS) in cancer management.
• To identify challenges and future directions for ERM-based PDT.

Main Methods:

• Literature review of studies employing ERMs for PS delivery in PDT.
• Analysis of enzyme-specific responses within the tumor microenvironment.
• Evaluation of ERM design strategies for enhanced PS targeting and release.

Main Results:

• ERMs can be engineered to respond to tumor-specific enzymes, enabling targeted PS delivery.
• This targeted delivery improves PS accumulation at the tumor site, enhancing PDT efficacy.
• ERMs reduce off-target PS distribution, thereby minimizing side effects on normal tissues.

Conclusions:

• ERMs represent a promising strategy to overcome the limitations of PS targeting in PDT.
• Further research into ERM design and characterization is crucial for advancing PDT applications.
• ERM-based PDT holds significant potential for improved cancer treatment outcomes.